José Vicente Marino
businessMale0.0Global Dominance: 0.00%
José Vicente Marino is the CEO of Aché, a prominent Brazilian pharmaceutical company that is expanding its production facilities and investing significantly in the research and development of generic medications in anticipation of upcoming patent expirations.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
José Vicente Marino, the CEO of Aché, states that a viable generic begins to be researched up to three years before it goes public.
veja como a indústria se preparaO Globo·
Brazil· 2025-08-17
Brazil· 2025-08-17
8.0